These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38460235)

  • 21. Generation of a control iPS cell line (JUCGRMi005-A) with no abnormalities in Parkinson's disease-related genes.
    Ishikawa KI; Shiga T; Funayama M; Hattori N; Akamatsu W
    Stem Cell Res; 2024 Feb; 74():103271. PubMed ID: 38100917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
    Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
    Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
    Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
    Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
    Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
    Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.
    Oleksy C; Massart F; Goldwurm S; Arado A; Arena G; Boussaad I; Krüger R
    Stem Cell Res; 2023 Oct; 72():103212. PubMed ID: 37832355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation.
    Jiang Z; Gu XJ; Su WM; Duan QQ; Lin JY; Cao B; Shang HF; Chen YP
    Stem Cell Res; 2022 Oct; 64():102881. PubMed ID: 35944313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRP10 and α-synuclein transmission in Lewy body diseases.
    Carreras Mascaro A; Grochowska MM; Boumeester V; Dits NFJ; Bilgiҫ EN; Breedveld GJ; Vergouw L; de Jong FJ; van Royen ME; Bonifati V; Mandemakers W
    Cell Mol Life Sci; 2024 Feb; 81(1):75. PubMed ID: 38315424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
    Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
    Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease.
    Zheng X; Zhu Z; Chen K; Guo S; Liu T; Liu H
    Stem Cell Res; 2017 Aug; 23():119-121. PubMed ID: 28925360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
    Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of three hiPSC clones from a Parkinson's disease patient with a heterozygous variant of VPS35 p.D620N.
    Ishikawa KI; Ishiguro M; Li Y; Nishioka K; Hattori N; Akamatsu W
    Stem Cell Res; 2022 Apr; 60():102739. PubMed ID: 35247840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
    Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
    Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of LRP10 mutations in Parkinson's disease patients from Italy.
    Manini A; Straniero L; Monfrini E; Percetti M; Vizziello M; Franco G; Rimoldi V; Zecchinelli A; Pezzoli G; Corti S; Comi GP; Duga S; Di Fonzo A
    Parkinsonism Relat Disord; 2021 Aug; 89():17-21. PubMed ID: 34216936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
    Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
    Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
    Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRP10 variants in Parkinson's disease and dementia with Lewy bodies in the South-West of the Netherlands.
    Vergouw LJM; Ruitenberg A; Wong TH; Melhem S; Breedveld GJ; Criscuolo C; De Michele G; de Jong FJ; Bonifati V; van Swieten JC; Quadri M
    Parkinsonism Relat Disord; 2019 Aug; 65():243-247. PubMed ID: 31147221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.